Published online Aug 27, 2026. doi: 10.4240/wjgs.121170
Revised: April 10, 2026
Accepted: June 4, 2026
Published online: August 27, 2026
Processing time: 152 Days and 15.8 Hours
Spontaneous esophageal rupture (Boerhaave syndrome) remains a life-threa
A 65-year-old man underwent conservative management of spontaneous esopha
OTSC can effectively treat refractory chronic fistulas developing after spontaneous esophageal rupture in patients for whom surgical intervention is high-risk.
Core Tip: The development of a chronic esophagopleural fistula following conservative management of Boerhaave syndrome is rare, such fistulas are difficult to treat, particularly in patients who are poor candidates for surgical intervention. We report a case in which a small chronic esophagopleural fistula was successfully closed using an over-the-scope clip combined with adequate pleural drainage and infection control. This case suggests that with appropriate patient selection and comprehensive management, over-the-scope clip can provide a minimally invasive and effective treatment option for chronic esophageal fistulas in high-risk surgical candidates.
- Citation: Takahashi N, Baba S, Toya Y, Nikai H, Fujisawa R, Endo F, Umemura A, Iwaya T, Nitta H, Sasaki A. Curative endoscopic closure of a chronic esophagopleural fistula after Boerhaave syndrome using an over-the-scope clip: A case report. World J Gastrointest Surg 2026; 18(8): 121170
- URL: https://www.wjgnet.com/1948-9366/full/v18/i8/121170.htm
- DOI: https://dx.doi.org/10.4240/wjgs.121170
Spontaneous esophageal rupture (Boerhaave syndrome) is a full-thickness perforation of the esophagus caused by a sudden increase in intraesophageal pressure, typically associated with forceful vomiting or severe retching. Although rare, with an estimated incidence of approximately only three cases per million people per year, it is considered one of the most lethal gastrointestinal perforations. Mortality rates range from 20% to 40%, largely depending on the timing of diagnosis and therapeutic intervention, and untreated cases are reported to be almost uniformly fatal[1-3]. Contrast-enhanced chest computed tomography (CT) is the most useful imaging modality for the diagnosis of Boerhaave syn
Accordingly, recent treatment strategies have increasingly emphasized individualized management based on patient background and disease severity, combining conservative management, minimally invasive surgery, and endoscopic interventions as appropriate[3-10]. Conservative management may be effective in selected patients with contained per
With advances in endoscopic techniques, minimally invasive approaches using self-expandable metallic stents or the over-the-scope clip (OTSC) system have gained attention as alternative therapeutic options. OTSC provides strong full-thickness tissue approximation and has demonstrated efficacy in the closure of perforations and fistulas. However, its role in the management of chronic esophagopleural fistulous lesions developing after conservative treatment of Boer
Recurrent left-sided empyema approximately 1 year after spontaneous esophageal rupture.
A 65-year-old man with a history of chronic obstructive pulmonary disease was referred to our department for treatment of a refractory chronic esophagopleural fistula associated with recurrent left-sided empyema approximately 1 year after an episode of spontaneous esophageal rupture (Boerhaave syndrome). At the time of the initial event, he presented with sudden chest and back pain and was diagnosed with spontaneous esophageal rupture based on chest radiography, contrast esophagography, and CT (Figure 1). Because the patient developed respiratory failure and shock due to massive intrathoracic contamination and was considered a high-risk candidate for general anesthesia, conservative management was selected. He was treated with mechanical ventilation, esophageal decompression via a nasogastric tube, left pleural drainage, and intravenous antibiotic therapy. The esophageal perforation closed on day 59 after onset, and the patient was discharged on day 149 after symptom onset following clinical improvement.
After discharge, the patient developed recurrent left-sided pneumonia and empyema and required three-time hospitalizations at another institution. Further evaluation revealed persistent communication between the esophagus and the left pleural cavity, leading to the diagnosis of a refractory chronic esophagopleural fistula. The patient was referred to our department for surgical repair, but because of the presence of severe bilateral emphysema, thoracotomy was considered high-risk by the anesthesiology team, and endoscopic treatment was chosen.
The patient had a history of chronic obstructive pulmonary disease.
The patient had no remarkable personal or family history relevant to esophageal disease.
Upon admission to our department, the patient’s height was 172.0 cm, the body weight was 46.0 kg, the body tempera
The laboratory tests conducted showed a 7030/μL white blood cell count (normal range: 3300-8600 /μL), 11.8 g/dL hemoglobin level (normal range: 13.7-16.8 g/dL), 650000/μL platelet count (normal range: 158000-348000 /μL), 0.89 mg/dL serum creatinine level (normal range: 0.65-1.07 mg/dL), 9.8 mg/dL blood urea nitrogen level (normal range: 8.0-20.0 mg/dL), 14 IU/L aspartate aminotransferase level (normal range: 13-30 IU/L), 11 IU/L alanine aminotransferase level (normal range: 10-42 IU/L), and 0.10 mg/dL C-reactive protein level (normal range: 0.01-0.14 mg/dL). The culture of the pleural fluid yielded Pseudomonas aeruginosa.
Plain chest CT was performed at the time of transfer using a multidetector CT scanner. Axial images were acquired, and multiplanar reconstructions, including coronal views, were generated to assess the extent of the pleural abscess, the position of the drainage catheter, and the anatomical relationship between the lower esophagus and the left thoracic cavity. Because the purpose of this examination was to evaluate the presence of empyema and structural changes rather than active contrast leakage, contrast-enhanced CT was not performed at this stage. The CT images demonstrated an encapsulated fluid collection with an air-fluid level in the left thoracic cavity, consistent with empyema. Severe bilateral emphysematous changes were also observed (Figure 2A). The previously placed drainage tube was located within the abscess cavity in the left lower thorax (Figure 2B).
Upper gastrointestinal endoscopy revealed a well-demarcated fistulous opening approximately 2 mm in diameter on the left wall, just above the esophagogastric junction. The surrounding mucosa showed only mild erythema, without marked edema, necrosis, or severe fibrosis. The fistula margins were clearly identifiable, and tissue mobility was pre
Contrast esophagography was performed using a water-soluble contrast agent under fluoroscopic guidance. The examination was conducted in the standing position, with additional oblique views to optimize the visualization of the lower esophagus. Leakage was assessed in real time by observing the passage of contrast medium from the esophageal lumen into the left pleural cavity. A small amount of contrast leakage from the left wall just above the esophagogastric junction into the left thoracic cavity was observed, confirming persistent communication of the esophagopleural fistula (Figure 3B). The leakage was localized, and no massive extravasation or mediastinal spread was detected. No aspiration or bronchial communication was observed during contrast administration.
Based on the clinical, radiological, and laboratory findings, the severity of empyema was assessed using the RAPID score[13], which incorporates renal function, age, purulence, infection source, and dietary factors, and a moderate- to high-risk category was suggested. In addition, the patient’s chronic obstructive pulmonary disease was severe according to the Global Initiative for Chronic Obstructive Lung Disease classification system[14], in conjunction with the marked bilateral emphysematous changes observed on CT. The presence of persistent pleural infection and reduced pulmonary reserve was considered to pose a high operative risk, particularly with regard to perioperative respiratory complications. Based on these pretreatment assessments, surgical intervention was deemed high-risk, and a less invasive endoscopic approach was selected.
Chronic esophagopleural fistula following conservative management of Boerhaave syndrome.
Because the fistula measured approximately 2 mm and the surrounding inflammation was minimal, full-thickness capture using OTSC was considered feasible. OTSC was selected over alternative endoscopic therapies (e.g., stenting, endoscopic vacuum therapy, or fibrin-based closure) because the defect was very small, the margins were viable and mobile, and secure full-thickness closure was considered achievable without the need for luminal diversion.
Under conscious sedation, upper gastrointestinal endoscopy was performed. An OTSC system (Ovesco Endoscopy, Tübingen, Germany) was mounted on the tip of the endoscope. To ensure secure closure of the fistula, a t type (trauma clip) with an 11 mm clip width and a 21 mm cap diameter was selected. The fistula was carefully positioned in the center of the endoscopic view with adequate insufflation to optimize visualization (Figure 4A). The fistulous opening and surrounding mucosa were suctioned into the OTSC cap, ensuring sufficient inversion of the tissue (Figure 4B). Because the fistula margins were clearly identifiable and tissue mobility was preserved, ancillary devices (e.g., a grasper or anchor) were not required. After confirmation of adequate tissue capture, the OTSC was deployed to achieve full-thickness closure (Figure 4C). Immediate post-deployment inspection demonstrated that the fistula was centered within the clip and that the surrounding mucosa was securely approximated. No immediate leakage was observed, and additional clips were not required (Figure 4D). Definitive closure was achieved using a single OTSC.
To ensure adequate infection control, the left pleural drain was exchanged, and continuous suction was maintained. Pleural lavage with 200 mL of saline twice daily was performed. The lavage protocol was selected to maintain drain patency and reduce the burden of pleural contamination while avoiding excessive intrathoracic fluid retention. Because pleural fluid culture yielded Pseudomonas aeruginosa, intravenous tazobactam/piperacillin (13.5 g/day) was administered from the day of transfer until postoperative day 14. Infection control was achieved in parallel with fistula closure rather than as a completely separate step. Because chronic esophagopleural fistulas carry a high risk of recurrence if infection persists, a comprehensive strategy combining mechanical closure and continuous pleural drainage and lavage was adopted.
Early enteral nutrition was resumed the day after OTSC placement. The contrast esophagography performed on postoperative day 14 demonstrated complete closure without leakage (Figure 5A). Oral intake was resumed on post
No procedure-related complications or adverse events were observed during the clinical course. During the 1-year of follow-up, contrast-enhanced CT was performed every 3 months to evaluate for recurrence of empyema, in addition to periodic chest radiography as clinically indicated. No recurrence of empyema or fistula reopening was observed, and no recurrent dysphagia, chest pain, fever, or respiratory symptoms suggestive of fistula recurrence were noted. The patient was satisfied with the minimally invasive treatment and the favorable clinical outcome without recurrence.
Spontaneous esophageal rupture (Boerhaave syndrome) remains a highly lethal clinical entity. The treatment strategy must be individualized according to the time from onset, the extent of perforation, the degree of contamination, and the patient’s overall condition. With advances in minimally invasive approaches, various therapeutic options, including conservative and endoscopic treatments, have been increasingly reported, in addition to surgical repair[3]. Although conservative management is appropriate in selected cases, late complications remain problematic[4].
Chronic esophagopleural fistulas are frequently accompanied by fibrotic changes around the fistulous tract and persistent thoracic infection. Surgical repair in such cases is often highly invasive, and in patients with severe comor
The OTSC system provides strong full-thickness tissue approximation and has demonstrated high clinical success rates for acute gastrointestinal perforations and leaks[11]. The reported clinical success rate in acute perforations is approximately 85%, whereas the outcomes in chronic fistulas are less favorable (around 50%)[12], reflecting the challenges posed by fibrosis and reduced tissue mobility. Hagel et al[15] reported that 11 of the 17 patients (64.7%) with gastrointestinal perforations requiring surgery in their study were successfully treated with OTSC, thereby avoiding surgical inter
In the present case, the fistula measured approximately 2 mm in diameter, and endoscopic examination revealed only mild mucosal inflammation, without marked fibrosis or necrosis. These characteristics likely facilitated effective full-thickness capture and closure using a single OTSC. Nevertheless, OTSC was not used as a stand-alone therapy. Adequate infection control through continuous pleural drainage and lavage was maintained before and after clip deployment. In chronic esophagopleural fistulas, closure of the luminal defect alone may not prevent recurrence if thoracic contamination persists. The combined strategy of mechanical closure and sustained drainage likely promoted stable tissue remodeling and prevented the re-accumulation of infected fluid. Previous reports have also suggested that comprehensive app
Alternative endoscopic options for esophageal fistulas include self-expandable metallic stents, endoscopic vacuum therapy, and tissue sealants, such as fibrin glue. However, stent therapy may be less suitable for a very small fistula because migration, patient discomfort, and the need for prolonged luminal coverage may outweigh the expected benefit[19,20]. Endoscopic vacuum therapy is effective in larger contaminated cavities but usually requires repeated endoscopic sessions and prolonged treatment[21,22]. Fibrin-based closure may be useful in selected low-output fistulas but may provide less reliable closure in the presence of persistent pleural contamination[23,24]. In the present case, OTSC was considered the most appropriate option because the defect was small, the surrounding tissue was viable and mobile, and full-thickness closure could be achieved in a single session while maintaining simultaneous pleural drainage.
The Pittsburgh esophageal perforation severity score (PSS) has been proposed as a useful tool for risk stratification in acute esophageal perforation[25]. At the initial presentation, the patient in the present case would have been classified as high-risk (PSS 6) based on non-contained perforation, respiratory distress, tachycardia, and pleural effusion on imaging. According to the treatment algorithms proposed by Schweigert et al[25], the initial choice of nonoperative management was reasonable in this context. The subsequent development of a chronic esophagopleural fistula is consistent with the increased risk of late complications in severe cases. However, PSS primarily applies to acute management and does not directly guide treatment decisions in the chronic phase. In late-presenting fistulas, careful evaluation of local tissue characteristics, infection status, and patient comorbidities is more clinically relevant than initial severity scoring[26,27].
In the present case, spontaneous dislodgement of the OTSC occurred on day 27 after placement, but no recurrence of leakage or empyema was observed. Contrast esophagography performed on day 14 had already confirmed complete closure of the fistula, suggesting that durable full-thickness healing had been achieved prior to clip detachment. In addition, continuous pleural drainage and lavage provided adequate infection control, thereby promoting stable tissue remodeling and mucosal reepithelialization. Therefore, the absence of recurrence despite clip dislodgement can be reasonably explained by definitive fistula healing before device detachment. This clinical course indicates that when sufficient infection control and drainage are ensured, OTSC can facilitate durable closure even in chronic esophagopleural fistulas, and long-term clip retention itself may not be mandatory once tissue healing has been established.
This report has several limitations. First, it describes a single case, and the generalizability of the findings is limited. Second, long-term outcomes beyond 1 year remain unknown. Further studies are required to validate the effectiveness of OTSC in chronic esophagopleural fistulas.
In summary, this case suggests three practical conditions for successful OTSC closure in chronic post-Boerhaave fistulas: A small fistulous opening, viable and mobile tissue margins, and effective pleural drainage with adequate infection control. Conversely, OTSC may be less suitable in the presence of a large defect, severely fibrotic or necrotic margins, uncontrolled sepsis, or poor endoscopic access. In such situations, stent therapy, endoscopic vacuum therapy, or surgical repair may be more appropriate.
From a practical perspective, the treatment strategy for chronic esophagopleural fistulas may be summarized as follows: First, define the fistula size and tissue quality endoscopically; second, assess thoracic contamination and drainage adequacy; and third, select OTSC when the defect is small and tissue viability is preserved, while continuing drainage and infection control throughout the periprocedural period. The present case highlights that even in chronic esophago
The development of a chronic esophagopleural fistula after the conservative management of spontaneous esophageal rupture (Boerhaave syndrome) is a challenging clinical condition, particularly in patients with severe comorbidities in whom surgical intervention is high-risk. In the present case, careful assessment of local fistula characteristics combined with adequate infection control through continuous pleural drainage and lavage, together with OTSC placement, enabled curative treatment, even in the chronic phase. In chronic post-Boerhaave fistulas, OTSC may be considered when the defect is small, the margins are viable and mobile, and pleural infection is adequately controlled with drainage.
| 1. | Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC. Evolving options in the management of esophageal perforation. Ann Thorac Surg. 2004;77:1475-1483. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 665] [Cited by in RCA: 491] [Article Influence: 22.3] [Reference Citation Analysis (0)] |
| 2. | Predescu D, Achim F, Socea B, Rotariu A, Moraru AC, Rasuceanu A, Constantin C, Rosianu CG, Constantin A. Boerhaave Syndrome-Narrative Review. Diagnostics (Basel). 2025;15:2463. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 6] [Reference Citation Analysis (0)] |
| 3. | Pickering O, Pucher PH, De'Ath H, Abuawwad M, Kelly J, Underwood TJ, Noble F, Byrne JP. Minimally Invasive Approach in Boerhaave's Syndrome: Case Series and Systematic Review. J Laparoendosc Adv Surg Tech A. 2021;31:1254-1261. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 4] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 4. | Aloreidi K, Patel B, Ridgway T, Yeager T, Atiq M. Non-surgical management of Boerhaave's syndrome: a case series study and review of the literature. Endosc Int Open. 2018;6:E92-E97. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 11] [Cited by in RCA: 13] [Article Influence: 1.6] [Reference Citation Analysis (4)] |
| 5. | Aiolfi A, Micheletto G, Guerrazzi G, Bonitta G, Campanelli G, Bona D. Minimally invasive surgical management of Boerhaave's syndrome: a narrative literature review. J Thorac Dis. 2020;12:4411-4417. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 8] [Cited by in RCA: 22] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
| 6. | Sepesi B, Raymond DP, Peters JH. Esophageal perforation: surgical, endoscopic and medical management strategies. Curr Opin Gastroenterol. 2010;26:379-383. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 81] [Cited by in RCA: 62] [Article Influence: 3.9] [Reference Citation Analysis (0)] |
| 7. | Abbas G, Schuchert MJ, Pettiford BL, Pennathur A, Landreneau J, Landreneau J, Luketich JD, Landreneau RJ. Contemporaneous management of esophageal perforation. Surgery. 2009;146:749-55; discussion 755. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 194] [Cited by in RCA: 141] [Article Influence: 8.3] [Reference Citation Analysis (0)] |
| 8. | Freeman RK, Van Woerkom JM, Ascioti AJ. Esophageal stent placement for the treatment of iatrogenic intrathoracic esophageal perforation. Ann Thorac Surg. 2007;83:2003-7; discussion 2007. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 146] [Cited by in RCA: 121] [Article Influence: 6.4] [Reference Citation Analysis (1)] |
| 9. | Mennigen R, Colombo-Benkmann M, Senninger N, Laukoetter M. Endoscopic closure of postoperative gastrointestinal leakages and fistulas with the Over-the-Scope Clip (OTSC). J Gastrointest Surg. 2013;17:1058-1065. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 76] [Cited by in RCA: 60] [Article Influence: 4.6] [Reference Citation Analysis (1)] |
| 10. | Barakat MT, Girotra M, Banerjee S. (Re)building the Wall: Recurrent Boerhaave Syndrome Managed by Over-the-Scope Clip and Covered Metallic Stent Placement. Dig Dis Sci. 2018;63:1139-1142. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 9] [Cited by in RCA: 10] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
| 11. | Kirschniak A, Subotova N, Zieker D, Königsrainer A, Kratt T. The Over-The-Scope Clip (OTSC) for the treatment of gastrointestinal bleeding, perforations, and fistulas. Surg Endosc. 2011;25:2901-2905. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 195] [Cited by in RCA: 174] [Article Influence: 11.6] [Reference Citation Analysis (5)] |
| 12. | Kobara H, Mori H, Nishiyama N, Fujihara S, Okano K, Suzuki Y, Masaki T. Over-the-scope clip system: A review of 1517 cases over 9 years. J Gastroenterol Hepatol. 2019;34:22-30. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 181] [Cited by in RCA: 163] [Article Influence: 23.3] [Reference Citation Analysis (8)] |
| 13. | Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145:848-855. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 180] [Cited by in RCA: 134] [Article Influence: 11.2] [Reference Citation Analysis (0)] |
| 14. | Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-365. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3830] [Cited by in RCA: 3716] [Article Influence: 285.8] [Reference Citation Analysis (1)] |
| 15. | Hagel AF, Naegel A, Lindner AS, Kessler H, Matzel K, Dauth W, Neurath MF, Raithel M. Over-the-scope clip application yields a high rate of closure in gastrointestinal perforations and may reduce emergency surgery. J Gastrointest Surg. 2012;16:2132-2138. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 88] [Cited by in RCA: 69] [Article Influence: 4.9] [Reference Citation Analysis (4)] |
| 16. | Singh RR, Nussbaum JS, Kumta NA. Endoscopic management of perforations, leaks and fistulas. Transl Gastroenterol Hepatol. 2018;3:85. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 17] [Cited by in RCA: 34] [Article Influence: 4.3] [Reference Citation Analysis (4)] |
| 17. | Haito-Chavez Y, Law JK, Kratt T, Arezzo A, Verra M, Morino M, Sharaiha RZ, Poley JW, Kahaleh M, Thompson CC, Ryan MB, Choksi N, Elmunzer BJ, Gosain S, Goldberg EM, Modayil RJ, Stavropoulos SN, Schembre DB, DiMaio CJ, Chandrasekhara V, Hasan MK, Varadarajulu S, Hawes R, Gomez V, Woodward TA, Rubel-Cohen S, Fluxa F, Vleggaar FP, Akshintala VS, Raju GS, Khashab MA. International multicenter experience with an over-the-scope clipping device for endoscopic management of GI defects (with video). Gastrointest Endosc. 2014;80:610-622. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 260] [Cited by in RCA: 217] [Article Influence: 18.1] [Reference Citation Analysis (3)] |
| 18. | Kumar N, Sachan A, Muktesh G, Kochhar R, Samanta J. Successful Closure of a Rare Cause of Tracheoesophageal Fistula Using an Over-the-Scope Clip. ACG Case Rep J. 2022;9:e00880. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 3] [Article Influence: 0.8] [Reference Citation Analysis (1)] |
| 19. | Rosianu CG, Hoara P, Achim F, Birla R, Bolocan A, Mohssen A, Copca N, Constantinoiu S. The Use of Esophageal Stents in the Management of Postoperative Fistulas-Current Status, Clinical Outcomes and Perspectives-Review. Life (Basel). 2023;13:966. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 6] [Reference Citation Analysis (0)] |
| 20. | Shaqran TM, Engineer R, Abdalla EM, Alamoudi AA, Almahdi R, Aldhahri A, Alghamdi AM, Abufarea BM, Almutairi RF, Al-Suliman AA. The Management of Esophageal Perforation: A Systematic Review. Cureus. 2024;16:e63651. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 10] [Reference Citation Analysis (0)] |
| 21. | Le TM, Tran VH, Chung KS, Jeon SW. Endoscopic vacuum therapy for gastrointestinal transmural defects: a literature review. Clin Endosc. 2025;58:181-190. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 22. | Stathopoulos P, Zumblick M, Wächter S, Schiffmann L, Gress TM, Bartsch D, Seitz G, Denzer UW. Endoscopic vacuum therapy (EVT) for acute esophageal perforation: Could it replace surgery? Endosc Int Open. 2022;10:E686-E693. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 10] [Reference Citation Analysis (0)] |
| 23. | Amaya RP, Vargas RD, Ladino AC, Sánchez EF, Quintero CYS. Esophagogastric anastomotic leakage and anastomotic fistula: what can we do when endoluminal vacuum therapy fails? Gastroenterol Hepatol Open Access. 2023;14:197-201. [DOI] [Full Text] |
| 24. | Protopapas AA, Kyritsi V, Tsavdaris D, Mekras A, Savopoulos C, Michalopoulos A, Paramythiotis D. Endoscopic treatment of gastrointestinal perforations and leaks: Why, when, and how? World J Gastrointest Endosc. 2026;18:114033. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (6)] |
| 25. | Schweigert M, Sousa HS, Solymosi N, Yankulov A, Fernández MJ, Beattie R, Dubecz A, Rabl C, Law S, Tong D, Petrov D, Schäbitz A, Stadlhuber RJ, Gumpp J, Ofner D, McGuigan J, Costa-Maia J, Witzigmann H, Stein HJ. Spotlight on esophageal perforation: A multinational study using the Pittsburgh esophageal perforation severity scoring system. J Thorac Cardiovasc Surg. 2016;151:1002-1009. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 57] [Cited by in RCA: 73] [Article Influence: 6.6] [Reference Citation Analysis (0)] |
| 26. | Giulini L, Dubecz A, Schweigert M, Stein HJ. Traumatic oesophageal perforation: a successful management based on the Pittsburgh Perforation Severity Score. Eur J Cardiothorac Surg. 2019;55:792-794. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3] [Cited by in RCA: 3] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
| 27. | Athanasiou A, Spartalis E, Spartalis M, Griffiths EA. Management of oesophageal perforation based on the Pittsburgh Perforation Severity Score: still a matter of debate. Eur J Cardiothorac Surg. 2020;57:198. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 4] [Article Influence: 0.7] [Reference Citation Analysis (1)] |